Alvotech (ALVO)
USD 8.53
(-2.96%)
USD 8.53
(-2.96%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 91.43 Million USD | 10.12% |
| 2022 | 83.02 Million USD | 125.79% |
| 2021 | 36.77 Million USD | -44.8% |
| 2020 | 66.61 Million USD | 108.71% |
| 2019 | 31.91 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 12.43 Million USD | -76.72% |
| 2024 Q2 | 53.48 Million USD | 1498.98% |
| 2023 Q2 | 4.39 Million USD | -72.32% |
| 2023 Q1 | 15.86 Million USD | -33.51% |
| 2023 FY | 91.43 Million USD | 10.12% |
| 2023 Q3 | 17.78 Million USD | 305.12% |
| 2023 Q4 | 53.39 Million USD | 200.13% |
| 2022 Q1 | 452 Thousand USD | -98.7% |
| 2022 FY | 83.02 Million USD | 125.79% |
| 2022 Q4 | 23.85 Million USD | 25.22% |
| 2022 Q3 | 19.05 Million USD | -51.97% |
| 2022 Q2 | 39.66 Million USD | 8675.66% |
| 2021 FY | 36.77 Million USD | -44.8% |
| 2021 Q2 | 1.17 Million USD | 0.0% |
| 2021 Q3 | 536 Thousand USD | -54.5% |
| 2021 Q4 | 34.76 Million USD | 6385.82% |
| 2021 Q1 | 1.17 Million USD | -92.93% |
| 2020 FY | 66.61 Million USD | 108.71% |
| 2020 Q4 | 16.65 Million USD | 0.0% |
| 2020 Q3 | 16.65 Million USD | 0.0% |
| 2020 Q2 | 16.65 Million USD | 0.0% |
| 2020 Q1 | 16.65 Million USD | 108.71% |
| 2019 Q1 | 7.97 Million USD | 0.0% |
| 2019 Q2 | 7.97 Million USD | 0.0% |
| 2019 Q3 | 7.97 Million USD | 0.0% |
| 2019 Q4 | 7.97 Million USD | 0.0% |
| 2019 FY | 31.91 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | 83.867% |
| Embecta Corp. | 1.12 Billion USD | 91.842% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | 81.218% |
| Dynavax Technologies Corporation | 232.28 Million USD | 60.637% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | 21.404% |
| Pacira BioSciences, Inc. | 674.97 Million USD | 86.454% |
| PainReform Ltd. | - USD | -Infinity% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | -80.76% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -279.508% |
| SCYNEXIS, Inc. | 140.14 Million USD | 34.756% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -4641.205% |
| Cosmos Health Inc. | 53.37 Million USD | -71.299% |
| Journey Medical Corporation | 79.18 Million USD | -15.475% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -279.508% |
| Safety Shot Inc | 202.67 Thousand USD | -45014.719% |
| Alpha Teknova, Inc. | 36.68 Million USD | -149.248% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | 80.31% |
| Bright Green Corporation | 401.49 Thousand USD | -22673.611% |
| Procaps Group, S.A. | 409.92 Million USD | 77.695% |
| Theratechnologies Inc. | 81.76 Million USD | -11.827% |
| Harrow Health, Inc. | 130.19 Million USD | 29.77% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -617.974% |
| Biofrontera Inc. | 34.07 Million USD | -168.363% |
| DURECT Corporation | 8.54 Million USD | -969.654% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | 84.95% |
| Cronos Group Inc. | 88.84 Million USD | -2.919% |
| OptiNose, Inc. | 70.98 Million USD | -28.804% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | 79.348% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -1303.832% |
| Organogenesis Holdings Inc. | 433.14 Million USD | 78.89% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -646.488% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | -131.171% |
| Radius Health, Inc. | 2.88 Billion USD | 96.828% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -183.001% |
| ProPhase Labs, Inc. | 44.38 Million USD | -106.007% |
| Phibro Animal Health Corporation | 1.01 Billion USD | 91.015% |
| Procaps Group S.A. | 409.92 Million USD | 77.695% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -6922.581% |
| Viatris Inc. | 15.42 Billion USD | 99.407% |
| Rockwell Medical, Inc. | 83.61 Million USD | -9.355% |
| Aytu BioPharma, Inc. | 81 Million USD | -12.879% |
| SIGA Technologies, Inc. | 139.91 Million USD | 34.651% |
| Tilray Brands, Inc. | 788.94 Million USD | 88.411% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | 28.713% |
| Shineco, Inc. | 9.8 Million USD | -832.823% |
| PetIQ, Inc. | 1.1 Billion USD | 91.703% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -761850.0% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 95.155% |
| Alimera Sciences, Inc. | 80.75 Million USD | -13.225% |
| Silver Spike Investment Corp. | 11.72 Million USD | -680.012% |
| Assertio Holdings, Inc. | 152.06 Million USD | 39.873% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -1470.387% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -424.97% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -8394.386% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -226.982% |
| Hempacco Co., Inc. | 4.04 Million USD | -2160.064% |
| Talphera, Inc. | 651 Thousand USD | -13945.161% |
| Alvotech | 91.43 Million USD | 0.0% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | 71.121% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 92.947% |
| Currenc Group, Inc. | 53.25 Million USD | -71.69% |
| Kamada Ltd. | 144.75 Million USD | 36.837% |
| Indivior PLC | 1.09 Billion USD | 91.635% |
| Evoke Pharma, Inc. | 5.18 Million USD | -1664.92% |
| Flora Growth Corp. | 76.07 Million USD | -20.196% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -8394.386% |
| Evolus, Inc. | 202.08 Million USD | 54.755% |
| HUTCHMED (China) Limited | 837.99 Million USD | 89.089% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | 85.811% |
| Akanda Corp. | 2.16 Million USD | -4132.954% |